APA

Haas M., Yilmaz N., Schmidt A., Neyer U., Arneitz K., Stummvoll H. K., Wallner M., Auinger M., Arias I., Schneider B. & Mayer G. (19980921). Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease. Austrian Study Group of the Effects of Enalapril Treatment in Proteinuric Renal Disease. : Kidney & blood pressure research.

Chicago

Haas M, Yilmaz N, Schmidt A, Neyer U, Arneitz K, Stummvoll H K, Wallner M, Auinger M, Arias I, Schneider B and Mayer G. 19980921. Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease. Austrian Study Group of the Effects of Enalapril Treatment in Proteinuric Renal Disease. : Kidney & blood pressure research.

Harvard

Haas M., Yilmaz N., Schmidt A., Neyer U., Arneitz K., Stummvoll H. K., Wallner M., Auinger M., Arias I., Schneider B. and Mayer G. (19980921). Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease. Austrian Study Group of the Effects of Enalapril Treatment in Proteinuric Renal Disease. : Kidney & blood pressure research.

MLA

Haas M, Yilmaz N, Schmidt A, Neyer U, Arneitz K, Stummvoll H K, Wallner M, Auinger M, Arias I, Schneider B and Mayer G. Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease. Austrian Study Group of the Effects of Enalapril Treatment in Proteinuric Renal Disease. : Kidney & blood pressure research. 19980921.